Search

Your search keyword '"Endocarditis, Bacterial/surgery"' showing total 8 results
Start Over Descriptor "Endocarditis, Bacterial/surgery" Topic endocarditis, bacterial
8 results on '"Endocarditis, Bacterial/surgery"'

1. Modified Danielson Technique for Prosthetic Aortic Valve Endocarditis and Aortoventricular Discontinuity.

Author

Filippone G, Calia C, Finazzo M, Fazzari F, Caruana G, and Argano V

Subjects
Aged, Aortic Valve diagnostic imaging, Echocardiography methods, Endocarditis, Bacterial diagnosis, Endocarditis, Bacterial etiology, Heart Valve Prosthesis adverse effects, Humans, Male, Prosthesis-Related Infections diagnosis, Prosthesis-Related Infections etiology, Reoperation, Aortic Valve surgery, Cardiac Surgical Procedures methods, Endocarditis, Bacterial surgery, Prosthesis-Related Infections surgery
Abstract

Endocarditis is a devastating complication of prosthetic aortic valve replacement. The infective process can destroy aortic annulus tissue, making conventional surgical valve replacement difficult or impossible and causing aortoventricular discontinuity. Several treatment techniques have been proposed. One of these, the Danielson technique, involves translocating the aortic valve to the native ascending aorta, débriding the abscess cavity, closing the coronary ostia, and bypassing the coronary arteries with a Y anastomosis between 2 vein grafts. We describe our use of a modified Danielson technique in a 68-year-old man with advanced prosthetic valve endocarditis that was associated with aortic annulus destruction and aortoventricular discontinuity. This modified technique enables safer, more secure anchoring of a replacement valve, reduces the risks and concerns associated with bypass grafts, and successfully treats aortoventricular discontinuity., (© 2020 by the Texas Heart® Institute, Houston.)

Published
2020
Full Text
View/download PDF

2. Surgical treatment of endocarditis: current status.

Author

Pettersson GB

Subjects
Anti-Bacterial Agents therapeutic use, Debridement, Endocarditis, Bacterial diagnosis, Endocarditis, Bacterial microbiology, Heart Valve Prosthesis Implantation, Humans, Treatment Outcome, Cardiac Surgical Procedures, Endocarditis, Bacterial surgery
Published
2011

3. Tricuspid anterior leaflet replacement with autologous pericardium and polytetrafluoroethylene chordae, followed by edge-to-edge repair.

Author

García-Rinaldi R

Subjects
Humans, Polytetrafluoroethylene, Suture Techniques, Transplantation, Autologous, Cardiac Surgical Procedures methods, Endocarditis, Bacterial surgery, Heart Valve Diseases surgery, Pericardium transplantation, Tricuspid Valve
Abstract

Treatment of endocarditis of the tricuspid valve is very complex. Valvectomy without replacement can result in significant postoperative morbidity, and replacement is hazardous due to the possibility of prosthetic infection. Repair of the tricuspid valve is the best alternative. Many ingenious methods have been devised to repair the tricuspid valve in patients with infective endocarditis. However, repair of the endocarditic anterior leaflet presents a difficult surgical problem. We have developed a technique to replace the central portion of the anterior leaflet, in which most of the leaflet is excised and replaced with autologous pericardium. By preserving a small rim of the leaflet, we preserve the lateral and medial chordal attachments. Supplemental neochordae are created with polytetrafluoroethylene sutures. An edge-to-edge repair is used to correct residual insufficiency of the valve. We have used this technique in 4 patients. One patient died 1 month after surgery, but with a competent tricuspid valve. Three patients are now alive, 48, 34, and 1.5 months after surgery. Their tricuspid valves are functional, moving well, and competent. We conclude that the centrally infected anterior leaflet of the tricuspid valve can be replaced with autologous pericardium. The implantation of polytetrafluoroethylene neochordae and edge-to-edge repair can be used to achieve valve competence. Short- and medium-term follow-up in patients who have been treated with these techniques demonstrates that the valve remains fully mobile and competent.

Published
2007

4. Similar outcome of tricuspid valve repair and replacement for isolated tricuspid infective endocarditis

Author

Michele Di Mauro, Giorgia Bonalumi, Ilaria Giambuzzi, Guglielmo Mario Actis Dato, Paolo Centofanti, Alessandro Della Corte, Ester Della Ratta, Diego Cugola, Maurizio Merlo, Francesco Santini, Antonio Salsano, Mauro Rinaldi, Samuel Mancuso, Giangiuseppe Cappabianca, Cesare Beghi, Carlo De Vincentiis, Andrea Biondi, Ugolino Livi, Sandro Sponga, Davide Pacini, Giacomo Murana, Roberto Scrofani, Carlo Antona, Giovanni Cagnoni, Francesco Nicolini, Filippo Benassi, Michele De Bonis, Alberto Pozzoli, Marco Pano, Salvatore Nicolardi, Giosuè Falcetta, Andrea Colli, Francesco Musumeci, Riccardo Gherli, Enrico Vizzardi, Loris Salvador, Marco Picichè, Domenico Paparella, Vito Margari, Giovanni Troise, Emmanuel Villa, Yudit Dossena, Carla Lucarelli, Francesco Onorati, Giuseppe Faggian, Giovanni Mariscalco, Daniele Maselli, Fabio Barili, Alessandro Parolari, Roberto Lorusso, CTC, RS: Carim - V04 Surgical intervention, MUMC+: MA Med Staf Spec CTC (9), Di Mauro, Michele, Bonalumi, Giorgia, Giambuzzi, Ilaria, Dato, Guglielmo Mario Acti, Centofanti, Paolo, Corte, Alessandro Della, Ratta, Ester Della, Cugola, Diego, Merlo, Maurizio, Santini, Francesco, Salsano, Antonio, Rinaldi, Mauro, Mancuso, Samuel, Cappabianca, Giangiuseppe, Beghi, Cesare, De Vincentiis, Carlo, Biondi, Andrea, Livi, Ugolino, Sponga, Sandro, Pacini, Davide, Murana, Giacomo, Scrofani, Roberto, Antona, Carlo, Cagnoni, Giovanni, Nicolini, Francesco, Benassi, Filippo, De Bonis, Michele, Pozzoli, Alberto, Pano, Marco, Nicolardi, Salvatore, Falcetta, Giosuè, Colli, Andrea, Musumeci, Francesco, Gherli, Riccardo, Vizzardi, Enrico, Salvador, Lori, Picichè, Marco, Paparella, Domenico, Margari, Vito, Troise, Giovanni, Villa, Emmanuel, Dossena, Yudit, Lucarelli, Carla, Onorati, Francesco, Faggian, Giuseppe, Mariscalco, Giovanni, Maselli, Daniele, Barili, Fabio, Parolari, Alessandro, and Lorusso, Roberto

Subjects
MECHANICAL PROSTHESES, SURGERY, endocarditis, tricuspid valve, tricuspid valve repair, tricuspid valve replacement, tricuspid valve, tricuspid repair, tricuspid replacement, endocarditis, endocarditi, Tricuspid Valve/diagnostic imaging, MANAGEMENT, Humans, tricuspid replacement, Cardiac Surgical Procedures, METAANALYSIS, Endocarditis, Bacterial/surgery, Endocarditis, HEART-VALVE, MORTALITY, Endocarditis/surgery, Bacterial, Endocarditis, Bacterial, General Medicine, Treatment Outcome, Tricuspid Valve, Cardiac Surgical Procedures/adverse effects, tricuspid repair, Bacterial/surgery, Cardiology and Cardiovascular Medicine
Abstract

AIMS: To compare early and late mortality of acute isolated tricuspid valve infective endocarditis (TVIE) treated with valve repair or replacement.METHODS: Patients who were surgically treated for TVIE from 1983 to 2018 were retrieved from the Italian Registry for Surgical Treatment of Valve and Prosthesis Infective Endocarditis. All the patients were followed up by means of phone interview or calling patient referral physicians or cardiologists. Kaplan-Meier method was used to assess late survival and survival free from TVIE recurrence with log-rank test for univariate comparison. The primary end points were early mortality (30 days after surgery) and long-term survival free from TVIE recurrence.RESULTS: A total of 4084 patients were included in the registry. Among them, 149 patients were included in the study. Overall, 77 (51.7%) underwent TV repair and 72 (48.3%) TV replacement. Early mortality was 9% (13 patients). Expected early mortality according to EndoSCORE was 12%. The TV repair showed lower mortality and major complication rate (7% and 16%), compared with TV replacement (11% and 25%), but statistical significance was not reached. Median follow-up was 19.1 years (14.3-23.8). Late deaths were 30 and IE recurrences were 5. No difference in cardiac survival free from IE was found between the two groups after 20 years (80 ± 6% Repair Group vs 59 ± 13% Replacement Group, P = 0.3).CONCLUSIONS: Overall results indicate that once surgically addressed, TVIE has a low recurrence rate and excellent survival, apparently regardless of the type of surgery used to treat it.

Published
2022

5. Surgical treatment of patients with infective endocarditis: changes in temporal use, patient characteristics, and mortality-a nationwide study

Author

Andreas Dalsgaard Jensen, Lauge Østergaard, Jeppe K. Petersen, Peter Graversen, Jawad H. Butt, Henning Bundgaard, Claus Moser, Morten H. Smerup, Ivy S. Modrau, Kasper Iversen, Niels E. Bruun, Christian Torp-Pedersen, Gunnar Gislason, Andrew Wang, Sigurdur Ragnarsson, Jonas A. Povlsen, Lars Køber, and Emil L. Fosbøl

Subjects
RISK, Heart Valve Prosthesis Implantation, Male, Endocarditis, Bacterial/surgery, SPECTRUM, Endocarditis, Epidemiology, Endocarditis, Bacterial, Middle Aged, Endocarditis/diagnosis, TRENDS, Cardiac valve surgery, MANAGEMENT, Odds Ratio, Humans, Temporal trend, Registries, Infective endocarditis, Cardiology and Cardiovascular Medicine, Heart Valve Prosthesis Implantation/adverse effects, REGISTER, CARDIAC-SURGERY, Aged, Proportional Hazards Models
Abstract

Background Valve surgery guidelines for infective endocarditis (IE) are unchanged over decades and nationwide data about the use of valve surgery do not exist. Methods We included patients with first-time IE (1999–2018) using Danish nationwide registries. Proportions of valve surgery were reported for calendar periods (1999–2003, 2004–2008, 2009–2013, 2014–2018). Comparing calendar periods in multivariable analyses, we computed likelihoods of valve surgery with logistic regression and rates of 30 day postoperative mortality with Cox regression. Results We included 8804 patients with first-time IE; 1981 (22.5%) underwent surgery during admission, decreasing by calendar periods (N = 360 [24.4%], N = 483 [24.0%], N = 553 [23.5%], N = 585 [19.7%], P = P ≤ 0.001) and the proportion of males increased from 67.8% to 72.6% (P = 0.008) from 1999–2003 to 2014–2018. Compared with 1999–2003, associated likelihoods of valve surgery were: Odds ratio (OR) = 1.14 (95% CI: 0.96–1.35), OR = 1.20 (95% CI: 1.02–1.42), and OR = 1.10 (95% CI: 0.93–1.29) in 2004–2008, 2009–2013, and 2014–2018, respectively. 30 day postoperative mortalities were: 12.7%, 12.8%, 6.9%, and 9.7% by calendar periods. Compared with 1999–2003, associated mortality rates were: Hazard ratio (HR) = 0.96 (95% CI: 0.65–1.41), HR = 0.43 (95% CI: 0.28–0.67), and HR = 0.55 (95% CI 0.37–0.83) in 2004–2008, 2009–2013, and 2014–2018, respectively. Conclusions On a nationwide scale, 22.5% of patients with IE underwent valve surgery. Patient characteristics changed considerably and use of valve surgery decreased over time. The adjusted likelihood of valve surgery was similar between calendar periods with a trend towards an increase while rates of 30 day postoperative mortality decreased.

Published
2021
Full Text
View/download PDF

6. Infective endocarditis: Surgical management and prognostic predictors

Author

Madalena Coutinho Cruz, Rui Cruz Ferreira, Ana Galrinho, José Fragata, Luís Miranda, Rita Ilhão Moreira, and Luísa Moura Branco

Subjects
Adult, Male, lcsh:Diseases of the circulatory (Cardiovascular) system, medicine.medical_specialty, Adolescent, Pulmonary disease, Early detection, Disease, 030204 cardiovascular system & hematology, HSM CAR, HSM CCT, Postoperative Complications/mortality, Young Adult, 03 medical and health sciences, Postoperative Complications, 0302 clinical medicine, Cerebral embolism, Internal medicine, Humans, Medicine, Hospital Mortality, 030212 general & internal medicine, Young adult, General Environmental Science, Aged, Retrospective Studies, Aged, 80 and over, Endocarditis, Bacterial/surgery, business.industry, Retrospective cohort study, Endocarditis, Bacterial, Middle Aged, Prognosis, medicine.disease, Endocarditis, Bacterial/mortality, Increased risk, lcsh:RC666-701, Infective endocarditis, General Earth and Planetary Sciences, Female, Cardiology and Cardiovascular Medicine, business
Abstract

Introduction and Aim: Infective endocarditis (IE) is associated with high morbidity and mortality. It is important to determine which factors increase the risk of poor outcome in order to enable early detection and aggressive treatment, including surgery. The aim of our study was to identify factors predicting complications and in-hospital mortality in patients with IE and to analyze conditions predisposing to surgery and its outcome. Methods: We performed a retrospective study including patients with IE who underwent transesophageal echocardiography in a tertiary hospital center (2006-2014). Results: A total of 233 patients were analyzed (69.1% male; mean age 63.4±15.2 years; mean follow-up 28.4±30.7 months). The complication rate was 56.6% and in-hospital mortality was 16.3%. Independent predictors of mortality were chronic obstructive pulmonary disease (OR 4.89; CI 1.36-17.63; p=0.015), clinical course complicated by cerebral embolism (OR 9.38; CI 3.26-26.96; p

Published
2018
Full Text
View/download PDF

7. Biodegradable ring annuloplasty for valve repair in children with endocarditis

Author

Afksendiyos Kalangos, Erman Pektok, Mustafa Cikirikcioglu, and Patrick O. Myers

Subjects
Pulmonary and Respiratory Medicine, Heart Defects, Congenital, Male, medicine.medical_specialty, Heart Valve Diseases, Tricuspid Valve/surgery, Heart Defects, Congenital/complications, Streptococcal Infections/surgery, Streptococcal Infections, Heart Valve Diseases/surgery, Medicine, Endocarditis, Humans, Mitral Valve/surgery, Endocarditis, Bacterial/surgery, ddc:617, business.industry, Ring annuloplasty, Endocarditis, Bacterial, Staphylococcal Infections, medicine.disease, Staphylococcal Infections/surgery, Surgery, Mitral Valve, Female, Tricuspid Valve, Cardiology and Cardiovascular Medicine, business
Published
2012

8. Long-term outcome of infective endocarditis in non-intravenous drug users

Author

Manuel, Martínez-Sellés, Patricia, Muñoz, Alvaro, Estevez, Roberto, del Castillo, Miguel Angel, García-Fernández, Marta, Rodríguez-Créixems, Mar, Moreno, Emilio, Bouza, and Jose L, Vallejo

Subjects
Male, Endocarditis, Bacterial/Drug Therapy, Heart disease, Enfermedad cardiovascular, Tratamiento médico, Recurrence, Medicine, Hospital Mortality, Longitudinal Studies, Prospective Studies, Prospective cohort study, Hazard ratio, Age Factors, General Medicine, Staphylococcal Infections, Middle Aged, Patient Discharge, Survival Rate, Treatment Outcome, Infective endocarditis, Aortic Valve, Heart Valve Prosthesis, Endocarditis, Bacterial/*Mortality, Substance-Related Disorders/*Complications, Mitral Valve, Endocarditis, Bacterial/Surgery, Mitral Valve/Microbiology, Female, Adult, Streptococcal Infections/Mortality, medicine.medical_specialty, Heart Diseases, Spain/Epidemiology, Substance-Related Disorders, Aortic Valve/Microbiology, Streptococcal Infections, Endocarditis, Humans, Staphylococcal Infections/Mortality, Survival rate, Aged, Heart Diseases/Complications, business.industry, Endocarditis, Bacterial, medicine.disease, Comorbidity, Confidence interval, Heart Valve Prosthesis/Microbiology, Surgery, Spain, Patient Discharge/Statistics & Numerical Data, business, Follow-Up Studies
Abstract

Objective: Patients and Methods: Results: Conclusion: To describe postdischarge survival rates and late complications in non-intravenous drug users (non-IVDUs) after treatment of infective endocarditis (IE).This prospective study consists of consecutive cases of IE in non-IVDUs seen between January 1, 1994, and August 31, 2005. Patient treatment (ie, pharmaceutical and/or surgical) and cardiac valve involved in infection (ie, aortic and/or mitral; whether valve was native or prosthetic) were recorded. Patient follow-up, to March 31, 2007, occurred at 1, 2, 3, and 4 years. Complications, survival, and mortality were statistically analyzed.During the study period, 230 episodes of IE in 222 non-IVDUs were attended. A total of 143 patients (64%) were discharged from the hospital. Mean +/- SD age of discharged patients was 61+/-17 years. Survival at 1-, 2-, 3-, and 4-year follow-up was 88%, 82%, 76%, and 67%, respectively. Survival was similar for patients with native-valve IE and those with prosthetic-valve IE. The only independent predictors of long-term mortality after discharge were age (hazard ratio, 1.04; 95% confidence interval, 1.01-1.06+/- P=.002) and comorbidity (Charlson index HR, 1.33; 95% confidence interval, 1.18-1.49; P

Published
2008

Catalog

Books, media, physical & digital resources
See catalog results